MedTrace Logo

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

NCT03435172 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-09-25

No results posted yet for this study

Summary

The primary objective of the protocol is to evaluate preliminary safety and feasibility of ADRCs via intravenous delivery in the treatment of deep partial and full thickness thermal wounds.

Conditions

  • Thermal Burn

Interventions

DEVICE

Device-ADRCs intravenously infusion

Medical Device: ADRCs Generated by Celution 800 IV Device and then Infused into Peripheral Vein.

Sponsors & Collaborators

  • Cytori Therapeutics

    lead INDUSTRY

Principal Investigators

  • Marc H Hedrick, MD · Cytori therapeutics Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-07-31
Completion
2021-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03435172 on ClinicalTrials.gov